大血管炎18F-FDG PET血管活性半定量与定性测量方法的比较
半定量评估的ICC为0.99,高于定性的0.82;肝组织本底比(TBRLiver)的AUC最高(0.66),半定量方法可靠性更优且在严重炎症时能更好区分治疗反应。
要点
- 半定量评估ICC为0.99,高于定性评估的0.82。
- PETVAS与TBR指标较SUV指标与PET判读活动性关联更强。
- TBRLiver的AUC最高(0.66),半定量在严重炎症时提供补充信息。
核心结论
- 定性与半定量方法均可用于评估和监测大血管炎的血管炎症。
- 半定量方法较定性方法可靠性更优,且在严重炎症时能更好区分治疗反应。
研究设计与样本
- 由中心判读者评估PET血管活动性,动脉摄取采用PETVAS定性评分及SUV和TBR半定量评分。
- 以医师临床疾病活动度评估和判读者PET血管活动性判读为独立参考标准,采用ICC和ROC曲线下面积评估各方法性能。
主要发现
- 半定量评估ICC为0.99(范围0.98-1.00),高于定性评估的0.82(范围0.56-0.93)。
- PETVAS和TBR指标较SUV指标与判读者PET活动性判读关联更强。
- 所有评估方法均与医师临床疾病活动度评估显著相关,其中TBRLiver的ROC曲线下面积最高(0.66)。
- SUV指标(r=0.19,P<0.01)和TBRLiver(r=0.20,P<0.01)与C反应蛋白呈显著但弱相关,PETVAS则无。
- 56例患者加强治疗后,半定量(TBRLiver,1.31-1.23;变化6.1%;P<0.0001)和定性(PETVAS,22-18;P<0.0001)方法均显示动脉18F-FDG摄取显著降低。
关键数值与推荐
- 半定量ICC为0.99(范围0.98-1.00),定性ICC为0.82(范围0.56-0.93)。
- TBRLiver的ROC曲线下面积为0.66。
- SUV指标与CRP相关系数r=0.19(P<0.01),TBRLiver与CRP相关系数r=0.20(P<0.01)。
- 治疗加强后TBRLiver由1.31降至1.23(变化6.1%,P<0.0001),PETVAS由22降至18(P<0.0001)。
临床怎么用
- 在大血管炎PET评估中可优先采用半定量指标(如TBRLiver)以提高可靠性。
- 半定量方法可用于监测治疗反应,尤其在严重血管炎症病例中提供补充信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The study rationale was to assess the performance of qualitative and semiquantitative scoring methods for 18F-FDG PET assessment in large-vessel vasculitis. Methods: Patients with giant cell arteritis or Takayasu arteritis underwent independent clinical and imaging assessments within a prospective observational cohort. 18F-FDG PET/CT scans were interpreted for active vasculitis by central reader assessment. Arterial 18F-FDG uptake was scored by qualitative visual assessment using the PET vascular activity score (PETVAS) and by semiquantitative assessment using SUVs and target-to-background ratios (TBRs) relative to liver or blood activity. The performance of each scoring method was assessed by intrarater reliability using the intraclass correlation coefficient (ICC) and areas under the receiver-operating-characteristic curve, applying physician assessment of clinical disease activity and reader interpretation of vascular PET activity as independent reference standards. The Wilcoxon signed-rank test was used to analyze change in arterial 18F-FDG uptake over time. Results: Ninety-five patients (giant cell arteritis, 52; Takayasu arteritis, 43) contributed 212 18F-FDG PET studies. The ICC for semiquantitative evaluation (0.99 [range, 0.98-1.00]) was greater than the ICC for qualitative evaluation (0.82 [range, 0.56-0.93]). PETVAS and target-to-background ratio metrics were more strongly associated with reader interpretation of PET activity than SUV metrics. All assessment methods were significantly associated with physician assessment of clinical disease activity, but the semiquantitative metric liver tissue-to-background ratio (TBRLiver) achieved the highest area under the receiver-operating-characteristic curve (0.66). Significant but weak correlations with C-reactive protein were observed for SUV metrics (r = 0.19, P < 0.01) and TBRLiver (r = 0.20, P < 0.01) but not for PETVAS. In response to increased treatment in 56 patients, arterial 18F-FDG uptake was significantly reduced when measured by semiquantitative (TBRLiver, 1.31-1.23; 6.1% change; P < 0.0001) or qualitative (PETVAS, 22-18; P < 0.0001) methods. Semiquantitative metrics provided information complementary to qualitative evaluation in cases of severe vascular inflammation. Conclusion: Both qualitative and semiquantitative methods of measuring arterial 18F-FDG uptake are useful in assessing and monitoring vascular inflammation in large-vessel vasculitis. Compared with qualitative metrics, semiquantitative methods have superior reliability and better discriminate treatment response in cases of severe inflammation.
引用
- Dashora HR, Rosenblum JS, Quinn KA, et al. Comparing Semiquantitative and Qualitative Methods of Vascular 18F-FDG PET Activity Measurement in Large-Vessel Vasculitis. J Nucl Med. 2021. PMID: 34088771. doi:10.2967/jnumed.121.262326
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。